n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, August 17th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

NanoVibronix, Inc. (NAOV)

Zacks, InvestorsHub, and MarketWatch reported on NanoVibronix, Inc. (NAOV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTC BB-listed, NanoVibronix, Inc. is a medical device company using its proprietary and patented low intensity surface acoustic wave technology. The Company’s pioneering technology allows for the creation of low-frequency ultrasound waves, which can be used for an array of medical applications, including the disruption of biofilms and bacteria colonization, and also providing pain relief. NanoVibronix has its headquarters in Elmsford, New York. The Company’s Research and Development (R&D) is in Nesher, Israel.

NanoVibronix’s products include PainShield®, UroShield™, NG-Shield™, and WoundShield™. These devices can undergo administration at home, without the aid of medical professionals. The PainShield® device is a wearable, battery powered electronic unit. It uses a disposable patch through which it delivers localized energy creating therapeutic effect to relieve localized pain and stimulate soft tissue healing.

The UroShield™ system is a multi-targeting solution. Its intention is to work against several factors, which are vital in preventing catheter related complications. The NG-Shield™ utilizes the Company’s proprietary acoustic technology onto the Nasogastric tube in such a way that it noticeably decreases the trauma and effective friction of the tube and blocks tube associated pain and discomfort.

The WoundShield™ system is a novel, patch-based therapeutic ultrasound device. It facilitates soft tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. The WoundShield™ may also be used to enhance oxygen and topical drugs delivery. In December 2016, NanoVibronix announced that it received clearance to sell the WoundShield™ in Canada.

This past March, NanoVibronix announced that it was granted a patent by the United States Patent and Trademark Office (USPTO) entitled, "System and Method for Surface Acoustic Wave Treatment of Skin," with a term through 2033, which does not include regulatory extensions.

The Company’s Surface Acoustic Wave (SAW) technology employs a portable patch-based therapeutic device to facilitate soft tissue regeneration by producing ultrasound surface acoustic waves on the skin to increase local capillary perfusion and tissue oxygenation. The surface acoustic waves extend beyond the skin contact area of the device. Therefore, this allows treatment of infected skin areas without painful contact between the device and the infected area.

Recently, NanoVibronix announced successful interim trial results for UroShield™. The trial was conducted at two skilled nursing facilities near Buffalo, New York, in which 22 subjects underwent evaluation.

Mr. Brian Murphy, NanoVibronix Chief Executive Officer, said, "We are very excited to report the results of this latest study, which reinforces our earlier pre-clinical data demonstrating a significant reduction in bacterial colonization on catheter devices when using UroShield™.”

NanoVibronix, Inc. (NAOV), closed Thursday's trading session at $5.80, even for the day. The average volume for the last 60 days is 1,348 and the stock's 52-week low/high is $4.75/$8.50.

Leatt Corp. (LEAT)

Nebula Stocks, TopPennyStockMovers, and SmallCapVoice reported previously onn Leatt Corp. (LEAT), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Leatt Corp. is a worldwide developer, marketer, and distributor of personal protective equipment for all kinds of sport, especially extreme high-velocity sports. Known for the invention of the first-of-its kind Leatt-brace®, Leatt’s range includes helmets, body protection, hydration packs, and gloves. This includes a new range of apparel unveiled in its 2017 product line. Also, other patents and products are undergoing development. Leatt is based in Durbanville, South Africa. The Company’s USA Distribution Office is in Santa Clarita, California.

Leatt has warehouses and the distribution office in Santa Clarita for the North American Market, New Zealand, and an international network of distributors. The Company’s primary area of emphasis is the prevention of neck injuries in persons wearing a crash helmet, for whatever purpose.

The Leatt-Brace® is an award-winning neck brace system. It is considered the gold standard for neck protection for any individual wearing a crash helmet as a form of protection. The design of it is for participants in extreme sports or riding motorcycles, bicycles, mountain bicycles, all-terrain vehicles, snowmobiles, and other vehicles.

Leatt has expanded its Motocross/Off-Road Range of products for 2017. The new portfolio adds a broad assortment of apparel designs, as well as high-performance protection gear, including new helmets. The new launch follows the Company’s launch of new bicycling products into new, wide-ranging consumer markets.

Last week, Leatt announced its financial results for Q2 and six months ended June 30, 2017. For the three months ended June 30, 2017, revenues were $3.5 million, with a net loss of $221,063, or $0.04 per share. This is in comparison to revenues of $3.7 million, with a net loss of $11,456, or $0.00 per share, for the 2016 Q2. For the six months ended June 30, 2017, revenues were $9.3 million, with net income of $50,897, or $0.01 per share. This is in comparison to revenues of $8.5 million, with net income of $101,524, or $0.02 per share, for the first half of 2016.

Mr. Sean Macdonald, Leatt Chief Executive Officer, said, "We expect to ship the 2018 product line to customers globally during the second half of 2017.  Our new line includes multiple new and refined Bike and Off-road Motorcycle products that continue to enable riders at all levels to push themselves further with the confidence provided by exceptional innovative protective gear. We look forward to presenting the new Bike range at the upcoming Eurobike exhibition in Germany from August 30 – September 2.”

Leatt Corp. (LEAT), closed Thursday's trading session at $1.75, down 5.41%, on 2,200 volume with 2 trades. The average volume for the last 60 days is 2,188 and the stock's 52-week low/high is $1.70/$4.00.

American Power Group Corp. (APGI)

Marketbeat, Stock News Now, and SmallCapVoice reported on American Power Group Corp. (APGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Power Group Corp. designs and produces proven alternative fuel solutions for stationary power generators, backup power systems, and commercial transportation. The Company’s alternative energy subsidiary, American Power Group, Inc. (APG), provides a cost-effective patented Turbocharged Natural Gas® Dual Fuel Conversion Technology for vehicular, stationary, as well as off-road mobile diesel engines. American Power Group is headquartered in Lynnfield, Massachusetts and lists on the OTC Markets Group’s OTCQB.

The Company’s patented Turbocharged Natural Gas® Dual Fuel Conversion Technology is a unique non-invasive software driven solution. It converts existing vehicular and stationary diesel engines to run simultaneously on diesel and different kinds of natural gas. This includes compressed natural gas, liquefied natural gas, conditioned well-head/ditch gas or bio-methane gas with the flexibility to return to 100 percent diesel fuel operation at any time.  It is a ground-breaking non-invasive energy enhancement system.

American Power Group (with its proprietary Flare to Fuel™ process technology) can convert captured gases into natural gas liquids (NGLs) that can sell as heating fluids, emulsifiers, or be further processed by refiners. Via the Company’s Trident Associated Gas Capture and Recovery Technology, it can provide oil and gas producers a flare capture service solution for associated gases produced at their remote and stranded well sites.  

Regarding American Power Group’s dual fuel, methane gas is metered into a diesel engine's air intake, before the turbocharger, by the air filter. As the enriched air/gas mixture increases the engine's power, the diesel's own governor senses the power increase and backs off on diesel flow. The system maintains a balance of gas-to-diesel ratios.

The maintaining of the energized fuel balance is with a proprietary read-only electronic controller system. This ensures the engines operate at original equipment manufacturers' (OEMs) specified temperatures and pressures. Installation on a broad collection of engine models and end-market applications demands no engine modifications.

Yesterday, American Power Group announced that it will extend the filing of its June 30, 2017 Quarterly Form 10Q through SEC Form 12b-25.  The Company announced on June 6, 2017, a corporate wide realignment of its strategic direction, reallocation of resources, and reduction in workforce in response to considerable operating losses because of the effect that ongoing low oil prices were having on its dual fuel and flare capture businesses. The realignment resulted in a decrease in annual operating costs of greater than $2 million on a going forward basis.

American Power Group Corp. (APGI), closed Thursday's trading session at $0.0142, up 1.43%, on 4,000 volume with 1 trade. The average volume for the last 60 days is 76,736 and the stock's 52-week low/high is $0.0102/$0.28.

Li3 Energy, Inc. (LIEG)

Ceocast News, FeedBlitz, TopPennyStockMovers, Streetwise Reports, Stockhouse, StockGuru, Pumps and Dumps, and PennyTrader Publisher reported earlier on Li3 Energy, Inc. (LIEG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Li3 Energy, Inc. is an exploration stage company in the lithium mining and energy sector. It is working to acquire, develop, and commercialize a substantial portfolio of lithium brine deposits in the Americas. The Company has its interest in the Maricunga project. Maricunga has an NI 43-101 (National Instrument) Measured Resource for a minimum 20-year life with considerable upside potential. It is the 4th top brine lithium project globally, out of 37 other brine salars. Li3 Energy is based in Santiago, Chile.

The Company has an advanced exploration stage lithium and potassium project within the Salar de Maricunga. This is the second largest lithium bearing salt brine deposit in Chile. The Salar de Maricunga is in Region III (Atacama region) of northern Chile at an elevation of roughly 3,750m.

With its interest in the Maricunga project, together with the completion of the NI 43–101 Compliant Measured Resource Report and the Cocina acquisition, Li3’ Energy has four chief goals. These are: to advance the Maricunga project to the Feasibility Stage; to support the global implementation of clean and green energy initiatives; and to meet growing lithium market demand; and to become a mid-tier, low cost supplier of lithium, potassium nitrate, iodine and other strategic minerals, serving international clients in the energy, fertilizer, and specialty chemical industries.

Li3 Energy is centering on further exploring, developing, and commercializing its flagship "Maricunga Project". This project consists of two adjacent properties:  60 percent controlling interest in SLM Litio 1-6 (1,438 hectares); and the Cocina Mining Concessions (450 hectares) acquired in April of 2013.

The Company has a strategic partnership with POSCO Canada Ltd. Li3 will continue its development of the Maricunga Project in Chile, together with a local strategic partner who will finance the project through to the permitting stage. Via POSCO, Li3 has been evaluating the use of advanced process technologies that may further improve upon the economics and shorten the commercial production timeline of the Maricunga Project.

Li3 Energy advised in September of 2016 that the legal and technical due diligence regarding the Maricunga Joint Venture (JV) between Lithium Power International Limited (LPI) and Minera Salar Blanco SpA (MSB) was satisfactorily completed. LPI entered into a binding and exclusive agreement with Chilean-based MSB for the exploration and development of the high-grade Maricunga lithium brine project in Chile, through the formation of new JV entity NewCo.

The resulting ownership structure of NewCo is LPI 50 percent, MSB 32.3 percent, and Li3 Energy 17.7 percent, with MSB and Li3 free-carried until the completion of a Definitive Feasibility Study in late 2018.

Li3 Energy announced this past January, with Bearing Resources Ltd., that on January 27, 2017 they entered into an agreement and plan of merger under which Bearing Resources has agreed to acquire Li3. With this Agreement, a newly‐formed wholly-owned subsidiary of Bearing will merge with and into Li3 Energy. Li3 will survive the Merger as a wholly-owned subsidiary of Bearing Resources.

Li3 Energy, Inc. (LIEG), closed Thursday's trading session at $0.02, up 5.26%, on 24,257 volume with 6 trades. The average volume for the last 60 days is 286,790 and the stock's 52-week low/high is $0.008/$0.055.

Uniroyal Global Engineered Products, Inc. (UNIR)

Zacks, Marketbeat, and MarketWatch reported on Uniroyal Global Engineered Products, Inc. (UNIR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Uniroyal Global Engineered Products, Inc., via its subsidiaries, is a top manufacturer of vinyl coated fabrics. These fabrics are durable, stain resistant, cost-effective alternatives to leather, cloth, and other synthetic fabric coverings. The Company is a foremost supplier of these vinyl coated fabric materials for the automotive and commercial industries. Established in 1992, Uniroyal Global Engineered Products (UNIR) is headquartered in Sarasota, Florida.

UNIR’s primary brand names include Naugahyde®, BeautyGard®, Flameblocker™, and Spirit Millennium®. Moreover, they include Ambla®, Amblon®, Velbex®, Cirroflex®, Plastolene® and Vynide®.  The Company’s 2016 revenue was derived 65 percent from the automotive industry and roughly 35 percent from the recreational, industrial, indoor and outdoor furnishings, hospitality, and health care markets

UNIR’s products in the automotive industry are used mostly in seating, door panels, head and arm rests, security shades, and trim components. The Company’s non-automotive applications include outdoor seating for utility and sports vehicles, and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pool liners, pram and nursery, movie screen, and decorative surface applications.

UNIR’s Naugahyde brand introduced Casablanca in 2016. This is a linen-textured vinyl-coated fabric. Casablanca combines the look and feel of linen with the performance of Naugahyde®.

The collection was developed with hospitality, contract, marine, as well as healthcare markets in mind. All of Casablanca’s patterns are flame retardant, stain resistant, and anti-microbial. Casablanca features Naugahyde’s exclusive Advanced BeautyGard® top coat finish.

Last week, UNIR reported its financial results for the second fiscal quarter ended July 2, 2017. Net sales for the second fiscal quarter were $26,077,549 in comparison to $27,333,869 for the prior year. This represents a decline of 4.6 percent.

Net sales for the six months ended July 2, 2017 were $51,835,978 in comparison to $52,301,464 for the prior year. This represents a decline of 0.9 percent.

Operating income for the second fiscal quarter was $1,644,302 in comparison to $2,614,414 for the second quarter of the prior year. This represents a decline of 37.1 percent. Operating income for the six months was $3,380,182 in comparison to $4,487,868 for the six months of the prior year. This represents a decline of 24.7 percent.

Net income Available to Common Shareholders declined in the second fiscal quarter to $214,466 from $1,181,726 in the second quarter of the prior year, due to lower gross profit margins. Net income Available to Common Shareholders for the six months ended July 2, 2017 declined to $685,242 from $1,615,829 in the first six months of the prior year, mainly because of lower gross profit margins.

Uniroyal Global Engineered Products, Inc. (UNIR), closed Thursday's trading session at $2.89, even for the day. The average volume for the last 60 days is 2,668 and the stock's 52-week low/high is $2.10/$3.80.

graphic

The QualityStocks
Company Corner

graphic
graphic

ABcann Global (TSX.V:ABCN) (OTCQB:ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF). Today, ABcann Global closed trading at $0.7106, off by 0.62%, on 125,787 volume with 103 trades. The stock’s average daily volume over the past 60 days is 48,149 and its 52-week low/high is $0.6171/$0.90.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global (TSX VENTURE: ABCN) (OTCQB: ABCCF), a client of NNW that is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. The publication, titled, "Investors Eye Sweet Spots in Canada's Booming Cannabis Market," highlights several public companies in the North American cannabis sector set to tackle opportunities within the burgeoning Canadian market. To view the full publication, visit: https://www.networknewswire.com/investors-eye-sweet-spots-canadas-booming-cannabis-market/

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) ABcann Medicinals, Inc. is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. One of the earliest licensed Canadian medical marijuana producers under Canada's federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space. The company currently owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario. Additionally, ABcann owns 65 acres of real estate with proper zoning and existing infrastructure in place to support the construction of another production facility of up to one million square feet.

In a November 2016 report, market research firm Canaccord Genuity Group forecasted that the medical marijuana market in Canada could see sales in excess of $8 billion by 2024, creating a sizable opportunity for the country's licensed producers (LPs). The research firm also noted that the "rigorous process of becoming a licensed producer of cannabis in Canada imposes significant barriers to entry and there will be a shortfall of supply in a legalized market in the short-term." This market barrier serves as a strategic advantage for ABcann as it prepares for its highly-anticipated IPO, which is currently scheduled for April 2017.

Canaccord's synopsis of the Canadian cannabis industry is supported by recent market activity, as companies sporting one of the illustrious Canadian government licenses for medicinal production have recorded strong growth following IPO. Canopy Growth (OTC: TWMJ), one of the largest fully-licensed Canadian marijuana growers, saw share prices skyrocket by more than 700 percent in the months following its initial offering. Aphria Inc. (OTC: APHQF), another licensed grower, climbed by more than 900 percent following its IPO. Other companies that have recorded huge growth since going public include Aurora Cannabis (OTC: ACBFF), climbing nearly 900 percent, and SupremePharma (OTC: SPRWF), which soared more than 1,300 percent.

With these market trends in mind, ABcann's impending IPO is one that prospective investors in the marijuana sector will want to explore. Recalls from some of the biggest players in the Canadian cannabis industry have highlighted the considerable learning curve that LPs face in today's market, which makes ABcann's proven track record in the market all the more noteworthy. The company has built a reputation over the years for its best-in-class standardized approach to growing cannabis, including the thoughtful omission of pesticides and a computer monitored growing technique that allows ABcann to minimize the risks of variance in its yields and ensure the creation of consistently high-quality products.

This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann's current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry. This global growth potential is illustrated by ABcann's partnership with Israel's Syqe Medical, producer of the world's first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting the company's production facility, Perry Davidson, founder of Syqe Medical, noted that ABcann's production technologies put it "in a class with the best in the world" in its ability to produce standardized pharmaceutical grade cannabis.

ABcann's entry into the public sector is being guided by a seasoned management team, board of directors and advisory board that feature well over a century of combined industry experience. Ken Clement, the company' founder and executive chairman, has been the key component and driving force behind ABcann's development since its inception. His vision of standardized production and dosage sets ABcann apart in the medical cannabis sector. Clement is joined on the company's management team by CEO Aaron Keay. Keay brings more than a decade of capital markets experience to ABcann, having played a role in raising approximately $250 million for public and private market issuers.

Notably, ABcann also has access to the 'Father of Cannabis Research', Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC), and he has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well-positioned to compete in the rapidly-expanding Canadian medicinal cannabis industry. These factors, along with the company's ongoing global expansion into the European, Australian and Israeli markets, show why ABcann Medicinals' upcoming public offering fits the bill as "Canada's Next Medical Marijuana IPO." Disclaimer

ABcann Global Blog

ABcann Global News:

NetworkNewsWire Announces Publication Discussing Public Companies Aiming to Take Advantage of Canada's Legal Marijuana Market

NetworkNewsWire Announces Publication Discussing the Companies Ready to Strike on the Canadian Legal Marijuana Industry

ABcann Goes from RTO to $43 Million in Cash in 3 Months -- CFN Media

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $0.404, off by 0.25%, on 89,451 volume with 54 trades. The stock’s average daily volume over the past 60 days is 77,471 and its 52-week low/high is $0.11/$0.699.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (CSE: LXX.CN) (CNSX: LXX) (OTCQB: LXRP), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. The publication, titled, "FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators," highlights multiple public companies developing new tobacco and nicotine devices in preparation for increasingly stringent FDA regulations. To view the full publication, visit: https://www.networknewswire.com/fda-proposal-puts-spotlight-big-tobacco-industry-innovators/

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

NetworkNewsWire Announces Publication Highlighting Companies Taking Innovative Strides in the Tobacco Industry

Lexaria Announces Exercised Warrants and Options

CEO Chris Bunka was Interviewed on Uptick Network Discussing Company’s Positive Future Progress

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.023, off by 8.00%, on 4,046,667 volume with 135 trades. The stock’s average daily volume over the past 60 days is 337,947, and its 52-week low/high is $0.0077/$0.04.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Global Payout, Inc. Finalizes Licensing Agreement with Cagney Global Logistics for the use of the Global Payout Technology Platform

Global Payout, Inc. and MoneyTrac Technology Enter the Multi-Billion Dollar CBD Market through their Agreement with H Smart, Inc.

Marijuana Company of America Completes $250,000 Investment in MoneyTrac Technology

Algae Dynamics Corp. (ADYNF)

The QualityStocks Daily Newsletter would like to spotlight Algae Dynamics Corp. (ADYNF). Today, Algae Dynamics Corp. closed trading at $0.08, even for the day, on 14,400 volume with 2 trades. The stock’s average daily volume over the past 60 days is 9,405 and its 52-week low/high is $0.0001/$0.62.

Algae Dynamics Corp. (ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.

The original core of the company's product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.

Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market's attractiveness can be further realized when considering that the Canada's licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company's initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market. Disclaimer

Algae Dynamics Corp. Blog

Algae Dynamics Corp. News:

Algae Dynamics Corp Enters Into a Letter of Intent with Bonify to Produce Unique Cannabis Oil Products; Accelerates Go-to-Market Strategy

NetworkNewsWire Releases Exclusive Audio Interview with Algae Dynamics Corp. (ADYNF)

Algae Dynamics Corp. (ADYNF) Engages NetworkNewsWire for Corporate Communications Solutions

Kootenay Zinc Corp. (CSE:ZNK) (OTCQB:KTNNF)

The QualityStocks Daily Newsletter would like to spotlight Kootenay Zinc Corp. (KTNNF). Today, Kootenay Zinc Corp. closed trading at $0.065, even for the day, on 21,300 volume with 4 trades. The stock’s average daily volume over the past 60 days is 33,903, and its 52-week low/high is $0.0475/$0.59.

Kootenay Zinc Corp. (KTNNF) is a mineral exploration and development company focused on discovering large-scale sedimentary-exhalative ("SEDEX") zinc deposits. Based in Vancouver, British Columbia, the company is ideally positioned near its primary target, the Sully Property, located 18 miles east of the world-class Sullivan Mine.

Of the 22 raw materials tracked by the Bloomberg Commodity Index, zinc was the best-performing base metal in 2016. Based on a widening global supply deficit, outlook for the commodity remains strong. As the most closely tied base metal to the Chinese economy, zinc demand and prices are expected to rise well into the year 2020, putting increased pressure on zinc supply.

For 2017, Goldman Sachs has predicted a 360,000 ton shortage of zinc, along with a subsequent rise in zinc prices to $2,500 per metric ton in the first half of the year. Zinc continues to make history in the metals exchange, driving significant interest in the market amid supply constraints in concentrates and refined metal drive prices.

Ready to claim its share of the market, Kootenay Zinc is focused on its Sully Property. It comprises 1,375 hectares and overlies rocks of similar age and origin as those which host the legendary Sullivan deposit. The Sullivan mine was discovered in 1892, and is known to be one of the world's largest SEDEX deposits. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately 300 million ounces of silver, 8 million tonnes of zinc and 8 million tonnes of lead.

Notably, geophysical data suggests that Kootenay Zinc's Sully project and Sullivan share many geological features:

  • Strata at Sully are in the same sedimentary basin as the Sullivan mine
  • The exact stratigraphic time horizon at which Sullivan formed is present at Sully
  • Filtered AeroMag anomalies coincident with Sullivan Time at Sully appear similar to Sullivan
  • Gravity anomaly at Sully indicates excess mass of comparable magnitude to Sullivan
  • Pb-Zn is present as traces in outcrop, drill core and in a soil geochemical anomaly

The squeeze in zinc supplies particularly affects China, which is both the world's largest zinc consumer and its largest producer, with 4.9 million tons of output in 2015. Chinese manufacturers are now being forced to import zinc for use in cars, household appliances, paints, rubber products and smartphones.

Zinc's rally shows no sign of slowing down in the near future, and companies that currently occupy stake in a zinc deposit find themselves in an enviable position over miners rushing to find new reserves. With its Sully Project, Kootenay Zinc could be on track to capture its share of the market, guided by a management team of mining directors and executives that currently lead some of the world's best mining companies and have been involved in world-class discoveries which sold for billions of dollars. The company's technical team includes industry experts that have worked on mega-mining projects, including the Sullivan and Voisey Bay projects. Disclaimer

Kootenay Zinc Corp. Company Blog

Kootenay Zinc Corp. News:

Sully Project - E3 Target Drilling Underway

Kootenay Zinc Corp.: Sully Project Exploration Update

NetworkNewsWire Releases Exclusive Audio Interview with Kootenay Zinc Corp. (KTNNF)

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

BUYINS.NET
(UVXY) +33.30%

2.

OTCBB Journal
(SPEX) +30.31%

3.

PennyDoctor
(NGTF) +24.59%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251